Your browser doesn't support javascript.
loading
Assessment of myocardial metabolic disorder associated with mediastinal radiotherapy for esophageal cancer -a pilot study.
Umezawa, Rei; Takanami, Kentaro; Kadoya, Noriyuki; Nakajima, Yujiro; Saito, Masahide; Ota, Hideki; Matsushita, Haruo; Sugawara, Toshiyuki; Kubozono, Masaki; Yamamoto, Takaya; Ishikawa, Yojiro; Takeda, Ken; Taki, Yasuyuki; Takase, Kei; Jingu, Keiichi.
  • Umezawa R; Department of Radiation Oncology, Tohoku University Graduate School of Medicine, Sendai, Japan. reirei513@hotmail.com.
  • Takanami K; Department of Diagnostic Radiology, Tohoku University Graduate School of Medicine, Sendai, Japan. pfpmf6212000@yahoo.co.jp.
  • Kadoya N; Department of Radiation Oncology, Tohoku University Graduate School of Medicine, Sendai, Japan. kadoya.n@rad.med.tohoku.ac.jp.
  • Nakajima Y; Department of Radiation Oncology, Tohoku University Graduate School of Medicine, Sendai, Japan. y.nakajima@med.tohoku.ac.jp.
  • Saito M; Department of Radiation Oncology, Tohoku University Graduate School of Medicine, Sendai, Japan. m.saito@med.tohoku.ac.jp.
  • Ota H; Department of Diagnostic Radiology, Tohoku University Graduate School of Medicine, Sendai, Japan. otahide@gmail.com.
  • Matsushita H; Department of Radiation Oncology, Tohoku University Graduate School of Medicine, Sendai, Japan. harumatsu2001@yahoo.co.jp.
  • Sugawara T; Department of Radiation Oncology, Tohoku University Graduate School of Medicine, Sendai, Japan. sugatosi772288@yahoo.co.jp.
  • Kubozono M; Department of Radiation Oncology, Tohoku University Graduate School of Medicine, Sendai, Japan. satoharuapple@yahoo.co.jp.
  • Yamamoto T; Department of Radiation Oncology, Tohoku University Graduate School of Medicine, Sendai, Japan. priere_for@yahoo.co.jp.
  • Ishikawa Y; Department of Radiation Oncology, Tohoku University Graduate School of Medicine, Sendai, Japan. y02614111@yahoo.co.jp.
  • Takeda K; Department of Radiological Technology, School of Health Sciences, Faculty of Medicine, Tohoku University, Sendai, Japan. takedak41@yahoo.co.jp.
  • Taki Y; Department of Developmental Cognitive Neuroscience Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan. ytaki@idac.tohoku.ac.jp.
  • Takase K; Department of Diagnostic Radiology, Tohoku University Graduate School of Medicine, Sendai, Japan. ktakase@rad.med.tohoku.ac.jp.
  • Jingu K; Department of Radiation Oncology, Tohoku University Graduate School of Medicine, Sendai, Japan. kjingurad@yahoo.co.jp.
Radiat Oncol ; 10: 96, 2015 Apr 21.
Article en En | MEDLINE | ID: mdl-25896887
ABSTRACT

BACKGROUND:

To evaluate the dose-effect relations for myocardial metabolic disorders after mediastinal radiotherapy (RT) by performing iodine-123 ß-methyl-iodophenyl pentadecanoic acid (I-123 BMIPP) scintigraphy.

METHODS:

Between 2011 and 2012, we performed I-123 BMIPP scintigraphy for patients with esophageal cancer before and six months after curative mediastinal RT. Single photon emission computed tomography (SPECT) images of pre-RT and post-RT were registered into RT dose distributions. The myocardium was contoured, and the regional RT dose was calculated. Normalization is required to compare pre- and post-RT SPECT images because the uptake pattern is changed due to the breathing level. Normalization was applied on the mean of SPECT counts in regions of the myocardium receiving less than 5 Gy. Relative values in each dose region (interval of 5 Gy) were calculated on the basis of this normalization for each patient. The reduction in the percent of relative values was calculated.

RESULTS:

Five patients were enrolled in this study. None of the patients had a past history of cardiac disease. The left ventricle was partially involved in RT fields in all patients. The patients received RT with median total doses of 60-66 Gy for the primary tumor and metastatic lymph nodes. Concomitant chemotherapy consisting of cisplatin or nedaplatin and 5-fluorouracil with RT was performed in 4 patients. All patients had reduced uptake corresponding to RT fields. Dose-effect relations for reduced uptake tended to be observed at 6 months after RT with mean decreases of 8.96% in regions at 10-15 Gy, 12.6% in regions at 20-25 Gy, 15.6% in regions at 30-35 Gy, 19.0% in regions at 40-45 Gy and 16.0% in regions at 50-55 Gy.

CONCLUSIONS:

Dose-effect relations for myocardial metabolic disorders tended to be observed. We may need to make an effort to reduce high-dose mediastinal RT to the myocardium in RT planning.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Traumatismos por Radiación / Neoplasias Esofágicas / Quimioradioterapia / Cardiopatías / Neoplasias del Mediastino / Enfermedades Metabólicas / Miocardio Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Aged / Aged80 / Humans / Male Idioma: En Año: 2015 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Traumatismos por Radiación / Neoplasias Esofágicas / Quimioradioterapia / Cardiopatías / Neoplasias del Mediastino / Enfermedades Metabólicas / Miocardio Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Aged / Aged80 / Humans / Male Idioma: En Año: 2015 Tipo del documento: Article